MedTrace Logo

Safety and Feasibility Study of the Eddii Mobile Application

NCT05205876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2022-10-05

No results posted yet for this study

Summary

The study is designed to measure the safety and feasibility of the Eddii mobile app for children living with Type-1 diabetes and using a CGM (Continuous Glucose monitor).

Conditions

  • Type-1 Diabetes

Interventions

BEHAVIORAL

Eddii mobile application

Participants will use the Eddii mobile application in the intervention arm.

Sponsors & Collaborators

  • Eddii, Inc.

    lead INDUSTRY

Principal Investigators

  • Farhaneh Ahmadi, PhD · Eddii, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-02
Primary Completion
2022-07-31
Completion
2022-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205876 on ClinicalTrials.gov